Title:
医薬組成物
Document Type and Number:
Japanese Patent JP6972256
Kind Code:
B2
Abstract:
A pharmaceutical composition is described. The composition comprises: (i) a drug component comprising at least one indacaterol compound selected from indacaterol and indacaterol maleate and at least one pharmaceutically acceptable salt of glycopyrrolate; and (ii) a propellant component at least 90 weight % of which is 1,1-difluoroethane (HFA-152a).
Inventors:
Stuart Cole
Timothy James Noks
Timothy James Noks
Application Number:
JP2020140692A
Publication Date:
November 24, 2021
Filing Date:
August 24, 2020
Export Citation:
Assignee:
Mexican Flow Ese a de se ve
International Classes:
A61K31/4704; A61K9/12; A61K9/72; A61K31/40; A61K31/573; A61K31/58; A61K47/06; A61K47/10; A61K47/12; A61K47/24; A61K47/32; A61M15/00; A61P11/00; A61P11/06; A61P43/00
Domestic Patent References:
| JP2014528470A | ||||
| JP2014505717A | ||||
| JP2014513146A |
Other References:
AAPS PharmSciTech,2014年,Vol.15, No.2,p.434-455
「フロン類の使用の合理化及び管理の適正化に関する法律施行規則第一条第三項及びフロン類算定漏えい量等の,環境省 経済産業省,2016年02月09日,p.1-5
「フロン類の使用の合理化及び管理の適正化に関する法律施行規則第一条第三項及びフロン類算定漏えい量等の,環境省 経済産業省,2016年02月09日,p.1-5
Attorney, Agent or Firm:
Masaharu Takamura
Hiroki Kashima
Yu Hasegawa
Hiroki Kashima
Yu Hasegawa
Previous Patent: Preparations, manufacturing methods and uses of hydrophobic therapeutic agents
Next Patent: Matching system
Next Patent: Matching system